In an autocrine manner, VCAM-1 can activate NF-κB via its receptor, very late antigen-4 (VLA-4, α4β1 integrin), to promote AML cells survival and confer chemoresistance on them [77]. The gene discussed is VCAM1; the disease is acute myeloid leukemia.